The global Felodipine Sustained-Release Tablet market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Felodipine Sustained-Release Tablet is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Felodipine Sustained-Release Tablet is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Felodipine Sustained-Release Tablet include Astrazeneca, NanJing Easeheal Phaemaecutical, SHANXI KANGBO BIOLOGICAL PRODUCT, Lifeon, Changzhou Siyao Pharmaceutical, Mylan and Sandoz, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Felodipine Sustained-Release Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Felodipine Sustained-Release Tablet.

Report Scope

The Felodipine Sustained-Release Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Felodipine Sustained-Release Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Felodipine Sustained-Release Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Felodipine Sustained-Release Tablet Market Report

Report Metric	Details
Report Name	Felodipine Sustained-Release Tablet Market
Segment by Type	2.5mg Per Tablet 5mg Per Tablet Others
Segment by Application	Treat High Blood Pressure Relieve Angina Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Astrazeneca, NanJing Easeheal Phaemaecutical, SHANXI KANGBO BIOLOGICAL PRODUCT, Lifeon, Changzhou Siyao Pharmaceutical, Mylan, Sandoz
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Felodipine Sustained-Release Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Felodipine Sustained-Release Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Felodipine Sustained-Release Tablet Market report?

Ans: The main players in the Felodipine Sustained-Release Tablet Market are Astrazeneca, NanJing Easeheal Phaemaecutical, SHANXI KANGBO BIOLOGICAL PRODUCT, Lifeon, Changzhou Siyao Pharmaceutical, Mylan, Sandoz

What are the Application segmentation covered in the Felodipine Sustained-Release Tablet Market report?

Ans: The Applications covered in the Felodipine Sustained-Release Tablet Market report are Treat High Blood Pressure, Relieve Angina, Others

What are the Type segmentation covered in the Felodipine Sustained-Release Tablet Market report?

Ans: The Types covered in the Felodipine Sustained-Release Tablet Market report are 2.5mg Per Tablet, 5mg Per Tablet, Others

1 Felodipine Sustained-Release Tablet Market Overview

1.1 Product Overview and Scope of Felodipine Sustained-Release Tablet

1.2 Felodipine Sustained-Release Tablet Segment by Type

1.2.1 Global Felodipine Sustained-Release Tablet Market Value Comparison by Type (2024-2030)

1.2.2 2.5mg Per Tablet

1.2.3 5mg Per Tablet

1.2.4 Others

1.3 Felodipine Sustained-Release Tablet Segment by Application

1.3.1 Global Felodipine Sustained-Release Tablet Market Value by Application: (2024-2030)

1.3.2 Treat High Blood Pressure

1.3.3 Relieve Angina

1.3.4 Others

1.4 Global Felodipine Sustained-Release Tablet Market Size Estimates and Forecasts

1.4.1 Global Felodipine Sustained-Release Tablet Revenue 2019-2030

1.4.2 Global Felodipine Sustained-Release Tablet Sales 2019-2030

1.4.3 Global Felodipine Sustained-Release Tablet Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Felodipine Sustained-Release Tablet Market Competition by Manufacturers

2.1 Global Felodipine Sustained-Release Tablet Sales Market Share by Manufacturers (2019-2024)

2.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Felodipine Sustained-Release Tablet Average Price by Manufacturers (2019-2024)

2.4 Global Felodipine Sustained-Release Tablet Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Felodipine Sustained-Release Tablet, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Felodipine Sustained-Release Tablet, Product Type & Application

2.7 Felodipine Sustained-Release Tablet Market Competitive Situation and Trends

2.7.1 Felodipine Sustained-Release Tablet Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Felodipine Sustained-Release Tablet Players Market Share by Revenue

2.7.3 Global Felodipine Sustained-Release Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Felodipine Sustained-Release Tablet Retrospective Market Scenario by Region

3.1 Global Felodipine Sustained-Release Tablet Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Felodipine Sustained-Release Tablet Global Felodipine Sustained-Release Tablet Sales by Region: 2019-2030

3.2.1 Global Felodipine Sustained-Release Tablet Sales by Region: 2019-2024

3.2.2 Global Felodipine Sustained-Release Tablet Sales by Region: 2025-2030

3.3 Global Felodipine Sustained-Release Tablet Global Felodipine Sustained-Release Tablet Revenue by Region: 2019-2030

3.3.1 Global Felodipine Sustained-Release Tablet Revenue by Region: 2019-2024

3.3.2 Global Felodipine Sustained-Release Tablet Revenue by Region: 2025-2030

3.4 North America Felodipine Sustained-Release Tablet Market Facts & Figures by Country

3.4.1 North America Felodipine Sustained-Release Tablet Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Felodipine Sustained-Release Tablet Sales by Country (2019-2030)

3.4.3 North America Felodipine Sustained-Release Tablet Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Felodipine Sustained-Release Tablet Market Facts & Figures by Country

3.5.1 Europe Felodipine Sustained-Release Tablet Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Felodipine Sustained-Release Tablet Sales by Country (2019-2030)

3.5.3 Europe Felodipine Sustained-Release Tablet Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Felodipine Sustained-Release Tablet Market Facts & Figures by Country

3.6.1 Asia Pacific Felodipine Sustained-Release Tablet Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Felodipine Sustained-Release Tablet Sales by Country (2019-2030)

3.6.3 Asia Pacific Felodipine Sustained-Release Tablet Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Felodipine Sustained-Release Tablet Market Facts & Figures by Country

3.7.1 Latin America Felodipine Sustained-Release Tablet Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Felodipine Sustained-Release Tablet Sales by Country (2019-2030)

3.7.3 Latin America Felodipine Sustained-Release Tablet Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Felodipine Sustained-Release Tablet Market Facts & Figures by Country

3.8.1 Middle East and Africa Felodipine Sustained-Release Tablet Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country (2019-2030)

3.8.3 Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Felodipine Sustained-Release Tablet Sales by Type (2019-2030)

4.1.1 Global Felodipine Sustained-Release Tablet Sales by Type (2019-2024)

4.1.2 Global Felodipine Sustained-Release Tablet Sales by Type (2025-2030)

4.1.3 Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2030)

4.2 Global Felodipine Sustained-Release Tablet Revenue by Type (2019-2030)

4.2.1 Global Felodipine Sustained-Release Tablet Revenue by Type (2019-2024)

4.2.2 Global Felodipine Sustained-Release Tablet Revenue by Type (2025-2030)

4.2.3 Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2019-2030)

4.3 Global Felodipine Sustained-Release Tablet Price by Type (2019-2030)

5 Segment by Application

5.1 Global Felodipine Sustained-Release Tablet Sales by Application (2019-2030)

5.1.1 Global Felodipine Sustained-Release Tablet Sales by Application (2019-2024)

5.1.2 Global Felodipine Sustained-Release Tablet Sales by Application (2025-2030)

5.1.3 Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2030)

5.2 Global Felodipine Sustained-Release Tablet Revenue by Application (2019-2030)

5.2.1 Global Felodipine Sustained-Release Tablet Revenue by Application (2019-2024)

5.2.2 Global Felodipine Sustained-Release Tablet Revenue by Application (2025-2030)

5.2.3 Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2019-2030)

5.3 Global Felodipine Sustained-Release Tablet Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Astrazeneca

6.1.1 Astrazeneca Corporation Information

6.1.2 Astrazeneca Description and Business Overview

6.1.3 Astrazeneca Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Astrazeneca Felodipine Sustained-Release Tablet Product Portfolio

6.1.5 Astrazeneca Recent Developments/Updates

6.2 NanJing Easeheal Phaemaecutical

6.2.1 NanJing Easeheal Phaemaecutical Corporation Information

6.2.2 NanJing Easeheal Phaemaecutical Description and Business Overview

6.2.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2019-2024)

6.2.4 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolio

6.2.5 NanJing Easeheal Phaemaecutical Recent Developments/Updates

6.3 SHANXI KANGBO BIOLOGICAL PRODUCT

6.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Corporation Information

6.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Description and Business Overview

6.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2019-2024)

6.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolio

6.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments/Updates

6.4 Lifeon

6.4.1 Lifeon Corporation Information

6.4.2 Lifeon Description and Business Overview

6.4.3 Lifeon Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Lifeon Felodipine Sustained-Release Tablet Product Portfolio

6.4.5 Lifeon Recent Developments/Updates

6.5 Changzhou Siyao Pharmaceutical

6.5.1 Changzhou Siyao Pharmaceutical Corporation Information

6.5.2 Changzhou Siyao Pharmaceutical Description and Business Overview

6.5.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolio

6.5.5 Changzhou Siyao Pharmaceutical Recent Developments/Updates

6.6 Mylan

6.6.1 Mylan Corporation Information

6.6.2 Mylan Description and Business Overview

6.6.3 Mylan Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Mylan Felodipine Sustained-Release Tablet Product Portfolio

6.6.5 Mylan Recent Developments/Updates

6.7 Sandoz

6.6.1 Sandoz Corporation Information

6.6.2 Sandoz Description and Business Overview

6.6.3 Sandoz Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sandoz Felodipine Sustained-Release Tablet Product Portfolio

6.7.5 Sandoz Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Felodipine Sustained-Release Tablet Industry Chain Analysis

7.2 Felodipine Sustained-Release Tablet Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Felodipine Sustained-Release Tablet Production Mode & Process

7.4 Felodipine Sustained-Release Tablet Sales and Marketing

7.4.1 Felodipine Sustained-Release Tablet Sales Channels

7.4.2 Felodipine Sustained-Release Tablet Distributors

7.5 Felodipine Sustained-Release Tablet Customers

8 Felodipine Sustained-Release Tablet Market Dynamics

8.1 Felodipine Sustained-Release Tablet Industry Trends

8.2 Felodipine Sustained-Release Tablet Market Drivers

8.3 Felodipine Sustained-Release Tablet Market Challenges

8.4 Felodipine Sustained-Release Tablet Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

NanJing Easeheal Phaemaecutical

SHANXI KANGBO BIOLOGICAL PRODUCT

LifeOn

Changzhou Siyao Pharmaceutical

Mylan NV

Sandoz Inc

List of Tables

Table 1. Global Felodipine Sustained-Release Tablet Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Felodipine Sustained-Release Tablet Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Felodipine Sustained-Release Tablet Market Competitive Situation by Manufacturers in 2023

Table 4. Global Felodipine Sustained-Release Tablet Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Felodipine Sustained-Release Tablet Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Felodipine Sustained-Release Tablet Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Felodipine Sustained-Release Tablet Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Felodipine Sustained-Release Tablet Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Felodipine Sustained-Release Tablet, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Felodipine Sustained-Release Tablet, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Felodipine Sustained-Release Tablet, Product Type & Application

Table 12. Global Key Manufacturers of Felodipine Sustained-Release Tablet, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Felodipine Sustained-Release Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Felodipine Sustained-Release Tablet as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Felodipine Sustained-Release Tablet Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Felodipine Sustained-Release Tablet Sales by Region (2019-2024) & (K Units)

Table 18. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2019-2024)

Table 19. Global Felodipine Sustained-Release Tablet Sales by Region (2025-2030) & (K Units)

Table 20. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2025-2030)

Table 21. Global Felodipine Sustained-Release Tablet Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2019-2024)

Table 23. Global Felodipine Sustained-Release Tablet Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2025-2030)

Table 25. North America Felodipine Sustained-Release Tablet Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Felodipine Sustained-Release Tablet Sales by Country (2019-2024) & (K Units)

Table 27. North America Felodipine Sustained-Release Tablet Sales by Country (2025-2030) & (K Units)

Table 28. North America Felodipine Sustained-Release Tablet Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Felodipine Sustained-Release Tablet Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Felodipine Sustained-Release Tablet Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Felodipine Sustained-Release Tablet Sales by Country (2019-2024) & (K Units)

Table 32. Europe Felodipine Sustained-Release Tablet Sales by Country (2025-2030) & (K Units)

Table 33. Europe Felodipine Sustained-Release Tablet Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Felodipine Sustained-Release Tablet Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Felodipine Sustained-Release Tablet Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Felodipine Sustained-Release Tablet Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Felodipine Sustained-Release Tablet Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Felodipine Sustained-Release Tablet Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Felodipine Sustained-Release Tablet Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Felodipine Sustained-Release Tablet Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Felodipine Sustained-Release Tablet Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Felodipine Sustained-Release Tablet Sales (K Units) by Type (2019-2024)

Table 51. Global Felodipine Sustained-Release Tablet Sales (K Units) by Type (2025-2030)

Table 52. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)

Table 53. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2025-2030)

Table 54. Global Felodipine Sustained-Release Tablet Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Felodipine Sustained-Release Tablet Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2019-2024)

Table 57. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2025-2030)

Table 58. Global Felodipine Sustained-Release Tablet Price (US$/Unit) by Type (2019-2024)

Table 59. Global Felodipine Sustained-Release Tablet Price (US$/Unit) by Type (2025-2030)

Table 60. Global Felodipine Sustained-Release Tablet Sales (K Units) by Application (2019-2024)

Table 61. Global Felodipine Sustained-Release Tablet Sales (K Units) by Application (2025-2030)

Table 62. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2024)

Table 63. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2025-2030)

Table 64. Global Felodipine Sustained-Release Tablet Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Felodipine Sustained-Release Tablet Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2019-2024)

Table 67. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2025-2030)

Table 68. Global Felodipine Sustained-Release Tablet Price (US$/Unit) by Application (2019-2024)

Table 69. Global Felodipine Sustained-Release Tablet Price (US$/Unit) by Application (2025-2030)

Table 70. Astrazeneca Corporation Information

Table 71. Astrazeneca Description and Business Overview

Table 72. Astrazeneca Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Astrazeneca Felodipine Sustained-Release Tablet Product

Table 74. Astrazeneca Recent Developments/Updates

Table 75. NanJing Easeheal Phaemaecutical Corporation Information

Table 76. NanJing Easeheal Phaemaecutical Description and Business Overview

Table 77. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product

Table 79. NanJing Easeheal Phaemaecutical Recent Developments/Updates

Table 80. SHANXI KANGBO BIOLOGICAL PRODUCT Corporation Information

Table 81. SHANXI KANGBO BIOLOGICAL PRODUCT Description and Business Overview

Table 82. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product

Table 84. SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments/Updates

Table 85. Lifeon Corporation Information

Table 86. Lifeon Description and Business Overview

Table 87. Lifeon Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Lifeon Felodipine Sustained-Release Tablet Product

Table 89. Lifeon Recent Developments/Updates

Table 90. Changzhou Siyao Pharmaceutical Corporation Information

Table 91. Changzhou Siyao Pharmaceutical Description and Business Overview

Table 92. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product

Table 94. Changzhou Siyao Pharmaceutical Recent Developments/Updates

Table 95. Mylan Corporation Information

Table 96. Mylan Description and Business Overview

Table 97. Mylan Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Mylan Felodipine Sustained-Release Tablet Product

Table 99. Mylan Recent Developments/Updates

Table 100. Sandoz Corporation Information

Table 101. Sandoz Description and Business Overview

Table 102. Sandoz Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Sandoz Felodipine Sustained-Release Tablet Product

Table 104. Sandoz Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Felodipine Sustained-Release Tablet Distributors List

Table 108. Felodipine Sustained-Release Tablet Customers List

Table 109. Felodipine Sustained-Release Tablet Market Trends

Table 110. Felodipine Sustained-Release Tablet Market Drivers

Table 111. Felodipine Sustained-Release Tablet Market Challenges

Table 112. Felodipine Sustained-Release Tablet Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Felodipine Sustained-Release Tablet

Figure 2. Global Felodipine Sustained-Release Tablet Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Felodipine Sustained-Release Tablet Market Share by Type in 2023 & 2030

Figure 4. 2.5mg Per Tablet Product Picture

Figure 5. 5mg Per Tablet Product Picture

Figure 6. Others Product Picture

Figure 7. Global Felodipine Sustained-Release Tablet Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Felodipine Sustained-Release Tablet Market Share by Application in 2023 & 2030

Figure 9. Treat High Blood Pressure

Figure 10. Relieve Angina

Figure 11. Others

Figure 12. Global Felodipine Sustained-Release Tablet Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Felodipine Sustained-Release Tablet Market Size (2019-2030) & (US$ Million)

Figure 14. Global Felodipine Sustained-Release Tablet Sales (2019-2030) & (K Units)

Figure 15. Global Felodipine Sustained-Release Tablet Average Price (US$/Unit) & (2019-2030)

Figure 16. Felodipine Sustained-Release Tablet Report Years Considered

Figure 17. Felodipine Sustained-Release Tablet Sales Share by Manufacturers in 2023

Figure 18. Global Felodipine Sustained-Release Tablet Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Felodipine Sustained-Release Tablet Players: Market Share by Revenue in 2023

Figure 20. Felodipine Sustained-Release Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Felodipine Sustained-Release Tablet Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Felodipine Sustained-Release Tablet Sales Market Share by Country (2019-2030)

Figure 23. North America Felodipine Sustained-Release Tablet Revenue Market Share by Country (2019-2030)

Figure 24. United States Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Felodipine Sustained-Release Tablet Sales Market Share by Country (2019-2030)

Figure 27. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Country (2019-2030)

Figure 28. Germany Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Felodipine Sustained-Release Tablet Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Felodipine Sustained-Release Tablet Revenue Market Share by Region (2019-2030)

Figure 35. China Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Felodipine Sustained-Release Tablet Sales Market Share by Country (2019-2030)

Figure 45. Latin America Felodipine Sustained-Release Tablet Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Felodipine Sustained-Release Tablet Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Felodipine Sustained-Release Tablet by Type (2019-2030)

Figure 55. Global Revenue Market Share of Felodipine Sustained-Release Tablet by Type (2019-2030)

Figure 56. Global Felodipine Sustained-Release Tablet Price (US$/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Felodipine Sustained-Release Tablet by Application (2019-2030)

Figure 58. Global Revenue Market Share of Felodipine Sustained-Release Tablet by Application (2019-2030)

Figure 59. Global Felodipine Sustained-Release Tablet Price (US$/Unit) by Application (2019-2030)

Figure 60. Felodipine Sustained-Release Tablet Value Chain

Figure 61. Felodipine Sustained-Release Tablet Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Endoparasiticide Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36H8345

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34R905

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2R9930

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34L14446

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions